Discontinued operations (Tables)

6 Months Ended

Jun. 30, 2016

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Results of Discontinued Operations

The following table summarizes the results of discontinued operations for the periods presented in the condensed consolidated statements of operations and comprehensive income (loss) for the three and six months ended June 30, 2016 and 2015 (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2016			2015			2016			2015
Revenues:
Net product revenue	$	(43	)	$	4,173		$	291		$	9,179
Operating expense:
Cost of product sold	—			612			15			1,952
Royalty expense	—			291			17			708
Research and development	—			1,020			—			5,829
Selling, general and administrative	539			3,097			1,010			14,233
Restructuring expense	—			568			—			568
Gain on sale of business	—			(89,053		)	—			(89,053		)
Total operating (income) expense	539			(83,465		)	1,042			(65,763		)
Other income	—			5,000			—			5,000
Net income (loss) from discontinued operations before tax	(582		)	92,638			(751		)	79,942
Income tax expense	—			(13,478		)	—			(13,478		)
Net income (loss) from discontinued operations	$	(582	)	$	79,160		$	(751	)	$	66,464

The following table summarizes the assets and liabilities of discontinued operations as of June 30, 2016 and December 31, 2015 related to the Zohydro ER business (in thousands):

	June 30, 2016		December 31, 2015
Assets
Current assets
Prepaid expenses and other current assets	$	—	$	208
Total current assets of discontinued operations	—		208
Total assets of discontinued operations	$	—	$	208
Liabilities
Current liabilities
Accounts payable	$	182	$	—
Accrued expenses	1,355		2,796
Deferred revenue and other current liabilities	—		110
Total current liabilities of discontinued operations	1,537		2,906
Total liabilities of discontinued operations	$	1,537	$	2,906